不同药物联合卡络磺钠对支气管扩张伴咯血中的临床疗效分析

doi:10.3969/j.issn.1006-6233.2018.05.046

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (1297 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To analyze the clinical effect of different drugs combined with kalo sodium in treatment of bronchiectasis with hemoptysis. Methods: A retrospective study was conducted on 60 patients with bronchiectasis with hemoptysis from January 2013 to December 2016. The 30 cases of patients were treated with phentolamine combined with cardosulfan sodium as the observation group. 30 cases of patients were treated with pituitrin combined with cardosulfan sodium as the control group. Comparison of two groups of patients with clinical efficacy, the average amount of bleeding and bleeding time, adverse reaction rate. Results: After treatment, there was no statistically significant difference in the total effective rate between the observation group and the control group (83.33% vs. 86.67%, P>0.05). The average blood loss (161.34±34.51vs. 155.22±34.23) and bleeding time (5.27±0.52vs. 5.38±0.51)d in the observation and control groups were not statistically different (P>0.05).The total adverse reaction rate of the observation group was significantly lower than that of the control group (20.00% vs.. 50.00% P<0.05). Conclusion: Phentolamine and pituitrin combined with cardulfonated sodium in the bronchiectasis with hemoptysis, can produce a good clinical efficacy, but phentolamine combined with cardulfonated sodium treatment of bronchiectasis with hemoptysis, which he reaction rate is low.

Key words： Bronchiectasis with hemoptysis Phentolamine Pituitrin Cardosulfan sodium

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2018.05.046 OR http://www.hbyxzzs.cn/EN/Y2018/V24/I5/873